These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28583269)

  • 1. The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis.
    Morgado-Carrasco D; Fustà-Novell X; Riera Monroig J; Mascaró Galy JM
    Actas Dermosifiliogr; 2017 Nov; 108(9):865-866. PubMed ID: 28583269
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of methotrexate in moderate to severe psoriasis patients: real-world registry data from the Swiss Dermatology Network for Targeted Therapies (SDNTT).
    Drach M; Papageorgiou K; Maul JT; Djamei V; Yawalkar N; Häusermann P; Anzengruber F; Navarini AA
    Arch Dermatol Res; 2019 Dec; 311(10):753-760. PubMed ID: 31396693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.
    Chiaravalloti AJ; Strober BE
    J Drugs Dermatol; 2014 Aug; 13(8):929-31. PubMed ID: 25116970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis: the new and the old.
    Feldman SR
    J Drugs Dermatol; 2014 Aug; 13(8):894. PubMed ID: 25116962
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R
    Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasis.
    Vidal D; Salleras M; Romaní J; Ribera M; Gallardo F; Viñas M; Xifra A; García-Navarro X; Bordas X; Ferran M; Carrascosa JM
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e131-e132. PubMed ID: 26446358
    [No Abstract]   [Full Text] [Related]  

  • 8. [News on psoriasis from the 2010 Dermatology Days in Paris].
    Boulinguez S
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H1-5. PubMed ID: 21703458
    [No Abstract]   [Full Text] [Related]  

  • 9. The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate.
    Choi CW; Kim BR; Seo E; Youn SW
    Br J Dermatol; 2017 Dec; 177(6):1740-1741. PubMed ID: 28129675
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012; 103(1):1-4. PubMed ID: 22093543
    [No Abstract]   [Full Text] [Related]  

  • 11. Split doses of Methotrexate in patients with moderate to severe Psoriasis.
    Rodríguez-Zúñiga MJM; Cortez-Franco F; Qujiano-Gomero E
    Actas Dermosifiliogr; 2017; 108(6):603-604. PubMed ID: 28173920
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P; Giglio MD; Girolomoni G
    J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for generalized pustular psoriasis in a 2-year-old child.
    Dogra S; Kumaran MS; Handa S; Kanwar AJ
    Pediatr Dermatol; 2005; 22(1):85-6. PubMed ID: 15660909
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate: new therapeutic approaches.
    Puig L
    Actas Dermosifiliogr; 2014; 105(6):583-9. PubMed ID: 23434058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate, a drug for the years to come.
    Naldi L; Saunes M
    Br J Dermatol; 2011 Aug; 165(2):230-1. PubMed ID: 21777212
    [No Abstract]   [Full Text] [Related]  

  • 17. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
    Barland C; Kerdel FA
    Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine.
    Ravindran S; Criton S
    Indian J Dermatol Venereol Leprol; 2019; 85(1):81-82. PubMed ID: 30457124
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.